Transactions by CHINA GRAND PHARMACEUTICAL A (512) in the last 6 months

China Grand Pharmaceutical and Healthcare Holdings Ltd. (SEHK:512) signed an agreement to acquire 3.39% stake in Grand Pharmaceutical (China) Company Limited from Wuhan KeyWin Venture Capital Co., Ltd. for CNY 20.1 million in cash on December 21, 2012. Purchase price will be paid within 3 working days from the date of the agreement becoming effective. The consideration will be settled by the internal resources. Grand Pharmaceutical (China) reported for the year ended ... December 31, 2011, turnover of CNY 1.21 million, profit before tax of CNY 0.08 million, profit after tax of CNY 0.06 million and net assets of CNY 501.60 million. The Directors consider that the terms of the agreement are fair and reasonable and are in the interests of China Grand and its shareholders. The transaction is subject to conditions including approval by shareholders of Grand Pharmaceutical (China) and shareholders, other than Wuhan KeyWin, providing written confirmations to confirm that they will not exercise the pre-emptive rights to acquire the stake Graham Lam of Guangdong Securities Limited acted as financial advisor for Board and shareholders of China Grand Pharmaceutical and Healthcare Holdings Ltd.
Read More

Sponsored Financial Commentaries

To contact CHINA GRAND PHARMACEUTICAL A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.